New Insights on the Addictions of Tumors


New Insights on the Addictions of Tumors
  1. New Insights on the Addictions of Tumors
    newswise.com
    Stromal tissue may provide novel targets to disrupt tumor supply…
    Medecine
< Previous Article Return to Article List

New Insights on the Addictions of Tumors

Stromal tissue may provide novel targets to disrupt tumor supply lines

Article ID: 682416

Released: 5-Oct-2017 5:05 PM EDT

Source Newsroom: Sanford Burnham Prebys Medical Discovery Institute

Add to Favorites more news from this source
  • Share
  • Credit: James Short

    Maria Diaz-Meco, Ph.D., is a professor in SBP's NCI-designated Cancer Institute

MEDIA CONTACT

Available for logged-in reporters only

CITATIONS

Cell Metabolism, Oct 2017

CHANNELS
All Journal News, Cancer, Cell Biology
KEYWORDS
  • SBP Medical Discovery Institute, Cancer, p62 protein, ATF4
  • Newswise — La Jolla, Calif., October 5, 2017 – Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego have shown that tumors can ensure a more reliable nutrient supply by eliminating the p62 protein in surrounding stromal tissue. Specifically, p62 deficiency helps tumors and stroma (supportive tissue outside the tumor) survive and grow, despite being deprived of glutamine, an essential amino acid.

    The study, published October 5 in Cell Metabolism, suggests that the p62 pathway in tumor stroma could be a potential anti-cancer target.

    “Cancer has traditionally been treated with chemotherapies that target oncogene addictions—the oncogenic signals that tumors use to survive,” says Maria Diaz-Meco, Ph.D., professor at SBP’s NCI-designated Cancer Center and senior author of the paper. “We are looking at the non-oncogenic addictions, which are the function of non-mutated genes that also contribute to the survival of many cancers.”

    “For example, the stroma is not the cancer, but it’s a major component that supports the tumor,” explains Diaz-Meco. “We believe that targeting metabolism, not only in mutated tumor cells but also in the stroma, will be a way to find new therapies, regardless of the cancer’s mutations.”

    Tumors must develop unique mechanisms to ensure adequate nutrient supplies. To do this, they rewire surrounding tissue, particularly cancer-associated fibroblasts in the stroma, which are hijacked to do the tumor’s bidding. Essentially, the cancer remodels its nest.

    “What happens when there’s nutrient stress?” asks Diaz-Meco. “The cancer doesn’t have supplies. In its more aggressive forms, nutrient accessibility inside the tumor becomes limited. The tumor eliminates p62 from the stroma to make the stroma more aggressive, more inflammatory and to be able to support the disease.”

    This is a common strategy in cancer, as p62 is often missing from stroma in breast, prostate, liver and other tumors.

    Diaz-Meco, along with fellow authors Jorge Moscat, Ph.D., professor and deputy director of SBP’s NCI-designation Cancer Center, and Christian Metallo, Ph.D., associate professor of bioengineering at UC San Diego, believe this stromal support could offer compelling ways to interfere with tumor supply lines. Because tumors are addicted to these mechanisms, it may be possible to target them without encountering significant resistance.

    “This offers new strategies to take advantage of the tumor’s vulnerabilities,” says Diaz-Meco. “We hope that targeting non-oncogenic addictions will generate less resistance, because the stroma is more genetically stable and does not mutate as tumor cells do during aggressive therapies.”

    In the study, the team found that reducing p62 increased ATF4, an essential transcription factor protein that instructs cells to adapt to situations in which nutrients are at a premium in the tumor microenvironment. ATF4 levels only changed in stroma, remaining constant in epithelial cells, regardless of p62 levels.

    Without ATF4, stromal cells in glutamine-free media stopped growing. Further exploration showed that p62 played a…

    1. Blue light cystoscopy improves bladder Ca detection

      Urologytimes.modernmedicine.com - Medecine
      Blue light flexible cystoscopy (D-Light C PDD Flexible Videoscope System) with intravesical hexaminolevulinate HCl (HAL [Cysview]) for surveillance in the office setting significantly improved the detection of recurrent bladder tumors compared with white light…
    2. Video visits in urology: How clinicians, patients benefit

      Urologytimes.modernmedicine.com - Medecine
      Among the many areas of telemedicine, a key opportunity exists for urologists in video visits, or “direct-to-consumer” tel…
    3. Tech advances catalyze paradigm shifts in patient care

      Urologytimes.modernmedicine.com - Medecine
      James M. Hotaling, MD, MS Steven A. Kaplan, MD Dr. Hotaling is assistant professor of surgery (urology) at the Center for Reconstructive Urology and Men's Health, University of Utah, Salt Lake City, and Dr. Kaplan is professor of urology, Icahn School of Medicine at Mount Sinai, New York.   Medicine is at a crossroads where the convergence of genetics, machine learning, bioinformatics, robotics, and point-of-care diagnostics have the ability to…
    4. Gavin Walsh of MarketStorm Global on How to Transform a Company Culture from Good to GREAT

      Bio-medicine.org - Medecine
      10.07 / 14:53 bio-medicine.org
      Miami, Florida (PRWEB) October 07, 2017 With offices across the world in the U.S, U.K, and Europe, CEO of MarketStorm Global knows a thing or two about not only establishing a positive company-wide culture but maintaining it too. About MarketStorm Global: …
    5. K&A Global Inc. Reveal How to Transform from Ordinary to Extraordinary

      Bio-medicine.org - Medecine
      10.07 / 14:53 bio-medicine.org
      Chicago, IL (PRWEB) October 07, 2017 Rizi Khan, President of the sales and marketing collective, outlined a number of ways to transform a life from lackluster and ordinary, to exciting and extraordinary. During a morning meeting, the business owner explained: “The difference between or…
    6. Informa Names Sixth Annual SupplySide CPG Editor’s Choice Award Winners

      Bio-medicine.org - Medecine
      10.07 / 14:53 bio-medicine.org
      Las Vegas, NV (PRWEB) October 06, 2017 Informa announced the winners of its 6th Annual SupplySide CPG Editor’s Choice Awards. The SupplySide and Natural Products INSIDER content team selected one consumer packaged goods (CPG) product for achievements in innovation and market impact in 27 ca…
    7. Mercy's Dr. Kevin Audlin First Physician in Mid-Atlantic Region to Use New Low-Impact Laparoscopic Surgery to Treat GYN

      Bio-medicine.org - Medecine
      10.07 / 14:53 bio-medicine.org
      Baltimore, MD (PRWEB) October 07, 2017 Kevin M. Audlin, M.D., FACOG , Co-Director of The Endometriosis Center in the Institute for Gynecologic Care at Mercy Medical Center , is the first physician in the mid-Atlantic region to use the new groundbreaking low impact laparoscopic surgery…
    8. Flossing Gorilla Underlines the Primal Importance of Good Oral Health, says Medical Center Dental Care

      Bio-medicine.org - Medecine
      10.07 / 14:53 bio-medicine.org
      Los Angeles, California (PRWEB) October 06, 2017 A September 28 article in The Daily Mail reports on the case of Kera, a Western Lowland Gorilla residing at England’s Bristol Zoo. Kera was spotted by photographer Miriam Haas, who caught her on film using a branch to clean out the spaces be…
    9. About 25% of People with Cancer Use Marijuana, Study Says

      Nationalpainreport.com - Medecine
      10.07 / 11:32 nationalpainreport.com
      By Staff. Approximately 25% of cancer patients uses marijuana in the past year for mostly physical and psychological pain, says a new study published in CANCER, a peer-reviewed journal of the American Cancer Society. The study was conducted in a cancer center in Washington, where medical and recreational marijuana is legal.  The study also …
    10. Facing Disaster: Every Little Thing Can Make a Difference

      Connection.asco.org - Medecine
      10.07 / 05:14 connection.asco.org
      By Enrique Soto Pérez de Celis, MD, MScInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán On Tuesday, September 19, at exactly 1:14 PM, a loud thump and a sudden fall were felt by everyone in Mexico City. What followed was a minute of shaking that felt like an eternity. As I huddled with my coworkers near the elevators on the seventh floor of our building, we all thought of the worst and hoped for the best. When the earth finally stood still, and as I climbed down the sta…
    11. Atossa Genetics (ATOS) Stock: Continues Skyward On Breast Cancer News

      Cnafinance.com - Medecine
      10.07 / 05:13 cnafinance.com
      Atossa Genetics Inc (NASDAQ:ATOS) is having yet another incredible day in the market today as investors continue to focus on the…
    12. Inovio Pharmaceuticals (INO) Stock: Gains On Clinical Data

      Cnafinance.com - Medecine
      10.07 / 05:13 cnafinance.com
      Inovio Pharmaceuticals Inc (NASDAQ: INO) is having a relatively strong start to the trading session this morning after the company reported…
    13. MannKind Corporation (MNKD) Stock: Continues Skyward | More To Come!

      Cnafinance.com - Medecine
      10.07 / 05:13 cnafinance.com
      MannKind Corporation (NASDAQ: MNKD) is having yet another incredible day in the market today following news of the FDA approved label…
    14. AVEO Pharmaceuticals (AVEO) Stock: Gaining On Study Analysis Completion

      Cnafinance.com - Medecine
      10.07 / 05:13 cnafinance.com
      AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is having an overwhelmingly strong start to the trading session this morning, and for good reason.…
    15. MannKind Corporation (MNKD): Continues To Run

      Cnafinance.com - Medecine
      10.07 / 05:13 cnafinance.com
      MannKind Corporation (NASDAQ: MNKD) is having yet another incredible day in the market today. The stock has been on a strong…
    16. HPV Testing Detects More Precancerous Lesions

      Labmedica.com -  Pathology
      10.07 / 05:12 labmedica.com
      Human papillomavirus (HPV) testing detects a higher number of precancerous cervical lesions than cytology-based Papanicolaou (Pap) smears in a…
    17. Genetic Test Discovered for Predicting Cancer Recurrence

      Labmedica.com -  Pathology
      10.07 / 05:12 labmedica.com
      Treatment failure, due to drug resistance, still remains a major obstacle for more effective anti-cancer therapy and personalized medicine.…
    18. Hematologic Abnormalities Found in HIV-Infected Children

      Labmedica.com - Hematology
      10.07 / 05:12 labmedica.com
      In both antiretroviral-treated and untreated individuals, different types of hematological abnormalities have been documented, the most important being pancytopenia.…
    19. CSF Pleocytosis Level Investigated as Diagnostic Predictor

      Labmedica.com - Hematology
      10.07 / 05:12 labmedica.com
      Migration of leukocytes to the cerebrospinal fluid is a cardinal symptom of an infectious condition affecting the meninges or…
    20. Automated Slide-Based Approach Introduced for CBCs

      Labmedica.com - Hematology
      10.07 / 05:12 labmedica.com
      The most commonly performed clinical laboratory test is the complete blood count (CBC). Currently, laboratory CBC systems obtain cell…